Company intelligence / Profile preview

Genective

Paris, Île-de-France, Francegenective.com ↗

Ownership: Private
Employees: ~37
Development stage: Other

Overview

Genective develops and commercializes transgenic traits—primarily insect resistance—for major crops like corn. The company has a strong research engine focused on next-generation insect control technologies using protein engineering and molecular biology. It holds several patents related to pesticidal genes and methods of use.

No clinical results as it does not develop human therapeutics.

Therapeutic areas: Other
Modalities: ProteinTransgenic trait technology
Industry: Agriculture & AgTech

Partnerships

LimagrainKWS Group

Beyond the preview

Go deeper on Genective.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genective.

Explore the full profile